Module

Debate Session – Strategic Approaches to Therapy: Advances and Challenges

Source: Advances in Lymphoproliferative Disease: From Molecular Pathogenesis to Multitargeted Treatment

Debate Session – Strategic Approaches to Therapy: Advances and Challenges

Program Director: Alexandra M. Levine, MD

Faculty:

Michael J. Keating, MB BS
Julie M. Vose, MD
Alexandra M. Levine, MD

CME CREDIT INFORMATION

Release Date: 08/26/08

Expiration Date: 08/25/09

Physicians: maximum of 0.5 AMA PRA Category 1 Credits™

Registered Nurses: 0.7 Nursing CE credits

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Cite the rationale for treatment selection to optimize outcomes in patients with chronic lymphocytic leukemia or indolent lymphoma
Identify the appropriate time to employ radioimmunotherapy as treatment for follicular lymphoma
Define the diagnostic characteristics of Richter’s syndrome and specify the optimal treatment strategies for this condition based on current evidence

Topics covered include:

Purine Analogues in the Treatment of Chronic Lymphocytic Leukemia or Indolent Lymphoma
Radioimmunotherapy in Follicular Lymphoma
Diagnosis and Treatment of Richter’s Syndrome
References

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.